EnPro Industries Acquires The Aseptic Group to Deliver Integrated Solutions for Biopharmaceuticals

On July 2, VCBeat (WeChat ID: vcbeat) learned from foreign media that leading industrial products manufacturer EnPro Industries, Inc. announced the acquisition of The Aseptic Group, a supplier of high-purity fluid handling systems, including its Aseptic Process Equipment SAS technology and Aseptic Services SARL services. Upon completion of the transaction, The Aseptic Group’s business will be merged with Garlock, a subsidiary of EnPro Industries. The deal will be completed as a cash transaction.

Aseptic Technologies designs and manufactures aseptic fluid transfer systems for the biopharmaceutical industry. As a global leading supplier of high-performance sealing products and fluid transfer systems to the processing industries, its aseptic process equipment specializes in fluid transfer within biopharmaceutical applications.

Aseptic Technologies, headquartered in Limonest, Lyon, France, is a recognized supplier of high-purity fluid transfer systems. For over two decades, it has been serving some of the world’s largest pharmaceutical companies. The company stands at the forefront of product development and is currently researching manufacturing technologies for next-generation biopharmaceutical aseptic packaging. Compared with traditional pharmaceutical manufacturing, this emerging industry demands higher operational standards, superior product quality, and more stringent regulatory compliance, thereby requiring absolute expertise, substantial capital investment, and meticulous service.

Garlock President Mike Faulkner stated, “The Aseptic Group’s focus is highly complementary to Garlock’s strategic market vision. With its expertise in product design, world-class manufacturing capabilities, and supply chain integrity, the Aseptic Group platform will provide significant value as we continue to build our global industrial presence. This transaction will enable us to further expand our product portfolio, deliver value-added solutions, and better support our most demanding customers.”

“Commenting on the transaction, Steve Macadam, President and Chief Executive Officer of EnPro Industries, stated: ‘The acquisition of The Aseptic Group demonstrates our commitment to continued investment in the biopharmaceutical industry. This move is a key component of Garlock’s strategic growth plan. We are particularly impressed by The Aseptic Group’s specialized expertise in the biopharmaceutical sector. We are delighted to welcome the employees of The Aseptic Group to EnPro and Garlock, and we believe this business combination will deliver benefits to our customers, the company, and our teams.’”

EnPro Industries, Inc. is an industry leader in sealing products, metal-polymer and fiber-wound bearings, components for reciprocating compressors and diesel and dual-fuel engines, as well as other industrial products, which are widely used across multiple industries worldwide. These products are sold globally, with nearly half of its sales revenue generated from outside the United States. EnPro Industries holds a strong market presence in the United States, Canada, the Asia-Pacific region, and Central and South America, serving customers in more than 100 countries annually. The company manufactures high-quality products and provides comprehensive after-sales support for systems and equipment. Its products serve over 40 different industries and encompass thousands of applications.

Garlock, a member of EnPro Industries, is a multinational manufacturer of high-performance fluid sealing and piping solutions, with a focus on safety, product longevity, and production efficiency. Garlock collaborates with customers, industry associations, and government agencies to understand their sealing requirements and deliver innovative solutions that ensure personnel safety while enhancing profitability.

(Compiled by Zhang Jing)